A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
Background/Aims The eradication rate of the first-line standard triple therapy (STT) for Helicobacter pylori (H. pylori) infection has decreased since 2000; therefore, other first-line therapies are required. This study was aimed at investigating the efficacy of bismuth-containing quadruple therapy...
Saved in:
Main Authors: | Sung Eun Kim (Author), Hye-Kyung Jung (Author), Seung Joo Kang (Author), Yong Chan Lee (Author), Hyo-Joon Yang (Author), Seon-Young Park (Author), Cheol Min Shin (Author), Hyun Chul Lim (Author), Jie-Hyun Kim (Author), Su Youn Nam (Author), Woon Geon Shin (Author), Jae Myung Park (Author), Il Ju Choi (Author), Jae Gyu Kim (Author), Miyoung Choi (Author) |
---|---|
Format: | Book |
Published: |
Yong Chan Lee,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Bismuth-based Quadruple Therapy as First-line Treatment for Clarithromycin-resistant Helicobacter pylori Infection
by: Seung In Seo, et al.
Published: (2022) -
Salvage Regimens after Failure of Previous Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Hyo-Joon Yang, et al.
Published: (2021) -
The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020) -
Comparison of the Dual Therapy of Ilaprazole-Amoxicillin and the Bismuth Quadruple Therapy of Ilaprazole-Amoxicillin-Furazolidone-Bismuth Glycyrrhizinate for Eradication of Helicobacter pylori
by: Min Niu, et al.
Published: (2022) -
Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
by: Hyun Soo Kim, et al.
Published: (2020)